Back in 2017, the FDIC accused Bank of America of refusing to pay over $500 million in assessments — a figure it later ...

RBC Capital initiated coverage of Ascendis Pharma (ASND) with an Outperform rating and $205 price target. The stock has outperformed the ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

The European Commission has granted the amyloid-beta monoclonal antibody Leqembi Marketing Authorization in the European Union. Lecanemab is ...

The most substantial impact comes from tariffs against China and retaliatory tariffs from China. Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year.

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

As temperatures begin to rise, homeowners everywhere are looking for ways to stay cool this summer. If you're thinking about a new AC unit, don't stress — financing options are available to make the ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to imposing tariffs ...

With broadcasts of the college football and NFL playoffs, as well as the men’s and women’s college basketball tournaments, many drugmakers looked to sports for advertising opportunities in Q1.